OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 28 citing articles:

Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment
Hailong Tian, Jiangjun Cao, Bowen Li, et al.
Bone Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 106

Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 16

TGF-β signaling networks in the tumor microenvironment
Max Kam‐Kwan Chan, Jeff Yat‐Fai Chung, Philip Chiu‐Tsun Tang, et al.
Cancer Letters (2022) Vol. 550, pp. 215925-215925
Closed Access | Times Cited: 48

Inflammatory Networks in Renal Cell Carcinoma
Linus Kruk, Medina Mamtimin, Attila Braun, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2212-2212
Open Access | Times Cited: 19

Cancer-educated neutrophils promote lung cancer progression via PARP-1-ALOX5-mediated MMP-9 expression
Lulu Han, Yuxin Chen, Nan Huang, et al.
Cancer Biology and Medicine (2024), pp. 1-18
Open Access | Times Cited: 6

The correlation between cancer stem cells and epithelial-mesenchymal transition: molecular mechanisms and significance in cancer theragnosis
Zi‐Ning Lei, Qiu-Xu Teng, Jagadish Koya, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5

Roles of anoikis in hepatocellular carcinoma: mechanisms and therapeutic potential
Chen Chen, Mengyao Wang, Daoyuan Tu, et al.
Medical Oncology (2025) Vol. 42, Iss. 3
Closed Access

Engineering inhalable nanomedicines to navigate lung barriers for effective pulmonary fibrosis therapy
Junlan Lu, Lin Sun, Mei Dong, et al.
Nano Today (2025) Vol. 64, pp. 102778-102778
Closed Access

The role of matrix stiffness in breast cancer progression: a review
Ruoxi Xu, Yin Peng, Ji‐Fu Wei, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 10

Research progress of nanomaterials in tumor-targeted drug delivery and imaging therapy
Liuru Fang, Yuhua Wang, Zu-zhao Xiong, et al.
OpenNano (2023) Vol. 14, pp. 100184-100184
Open Access | Times Cited: 8

Proton pump inhibitors display anti‐tumour potential in glioma
Bihan Li, Ying Liu, Shilong Sun
Cell Proliferation (2022) Vol. 56, Iss. 7
Open Access | Times Cited: 12

Pharmacological modulation of myeloid-derived suppressor cells to dampen inflammation
Chiel van Geffen, Constantin Heiss, Astrid Deißler, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 11

[Efficacy of combined treatment with pirfenidone and PD-L1 inhibitor in mice bearing ectopic bladder cancer xenograft].
Sheng Chen, Shuqun Zhang, Weijun Fan, et al.
PubMed (2024) Vol. 44, Iss. 2, pp. 210-216
Closed Access | Times Cited: 2

New insights into fibrotic signaling in renal cell carcinoma
Jiaoyi Chen, Wai-Han Yiu, Patrick Ming‐Kuen Tang, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 4

Suspended particulate matter promotes epithelial-to-mesenchymal transition in alveolar epithelial cells via TGF-β1-mediated ROS/IL-8/SMAD3 axis
Shahrzad Molavinia, Dian Dayer, Mohammad Javad Khodayar, et al.
Journal of Environmental Sciences (2023) Vol. 141, pp. 139-150
Closed Access | Times Cited: 4

Pirfenidone inhibits TGF‐β1‐induced metabolic reprogramming during epithelial‐mesenchymal transition in non‐small cell lung cancer
Shuling Zhang, Yuanmei Wang, Daiqin Luo, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 28, Iss. 3
Open Access | Times Cited: 4

Pirfenidone ameliorates alcohol-induced promotion of breast cancer in mice
Hui Li, Mei Xu, Danlei Chen, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1

Implications of c-Myc in the pathogenesis and treatment efficacy of urological cancers
Kiavash Hushmandi, Seyed Hassan Saadat, Mehdi Raei, et al.
Pathology - Research and Practice (2024) Vol. 259, pp. 155381-155381
Closed Access | Times Cited: 1

Metabolism and structure of PDA as the target for new therapies: possibilities and limitations for nanotechnology
Adrianna Zygmunt, Jerzy Gubernator
Expert Opinion on Drug Delivery (2024) Vol. 21, Iss. 6, pp. 845-865
Closed Access | Times Cited: 1

Decoding tumor-fibrosis interplay: mechanisms, impact on progression, and innovative therapeutic strategies
Huiguang Chen, Xuexin Xu, Jingxian Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1

Highlighting function of Wnt signalling in urological cancers: Molecular interactions, therapeutic strategies, and (nano)strategies
Mehrdad Hashemi, Mahdi Rezaei, Hadi Rezaeiaghdam, et al.
Translational Oncology (2024) Vol. 50, pp. 102145-102145
Open Access

Pirfenidone promotes cell cycle arrest and apoptosis of triple‑negative breast cancer cells by suppressing Hedgehog/GLI1 signaling
Shengyu Shi, Lingyu Zhao, C.F. Liu, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access

Page 1 - Next Page

Scroll to top